6LLQ

Solution NMR structure of de novo Rossmann2x2 fold with most of the core mutated to valine, R2x2_VAL88

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	500 uM [U-99% 13C; U-99% 15N] VAL88, 7.4 mM potassium phosphate, 1.2 mM sodium phosphate, 100 mM sodium chloride, 95 % H2O, 5 % [U-99% 2H] D2O	95% H2O/5% D2O	108.6 mM	6.0	1.0 atm	303	Bruker AVANCE III 800
2	2D 1H-13C HSQC aliphatic	500 uM [U-99% 13C; U-99% 15N] VAL88, 7.4 mM potassium phosphate, 1.2 mM sodium phosphate, 100 mM sodium chloride, 95 % H2O, 5 % [U-99% 2H] D2O	95% H2O/5% D2O	108.6 mM	6.0	1.0 atm	303	Bruker AVANCE III 800
3	2D 1H-13C HSQC aromatic	500 uM [U-99% 13C; U-99% 15N] VAL88, 7.4 mM potassium phosphate, 1.2 mM sodium phosphate, 100 mM sodium chloride, 95 % H2O, 5 % [U-99% 2H] D2O	95% H2O/5% D2O	108.6 mM	6.0	1.0 atm	303	Bruker AVANCE III 800
4	3D CBCA(CO)NH	500 uM [U-99% 13C; U-99% 15N] VAL88, 7.4 mM potassium phosphate, 1.2 mM sodium phosphate, 100 mM sodium chloride, 95 % H2O, 5 % [U-99% 2H] D2O	95% H2O/5% D2O	108.6 mM	6.0	1.0 atm	303	Bruker AVANCE III 800
5	3D HNCACB	500 uM [U-99% 13C; U-99% 15N] VAL88, 7.4 mM potassium phosphate, 1.2 mM sodium phosphate, 100 mM sodium chloride, 95 % H2O, 5 % [U-99% 2H] D2O	95% H2O/5% D2O	108.6 mM	6.0	1.0 atm	303	Bruker AVANCE III 800
6	3D H(CCO)NH	500 uM [U-99% 13C; U-99% 15N] VAL88, 7.4 mM potassium phosphate, 1.2 mM sodium phosphate, 100 mM sodium chloride, 95 % H2O, 5 % [U-99% 2H] D2O	95% H2O/5% D2O	108.6 mM	6.0	1.0 atm	303	Bruker AVANCE III 800
7	3D C(CO)NH	500 uM [U-99% 13C; U-99% 15N] VAL88, 7.4 mM potassium phosphate, 1.2 mM sodium phosphate, 100 mM sodium chloride, 95 % H2O, 5 % [U-99% 2H] D2O	95% H2O/5% D2O	108.6 mM	6.0	1.0 atm	303	Bruker AVANCE III 800
8	3D 1H-15N NOESY	500 uM [U-99% 13C; U-99% 15N] VAL88, 7.4 mM potassium phosphate, 1.2 mM sodium phosphate, 100 mM sodium chloride, 95 % H2O, 5 % [U-99% 2H] D2O	95% H2O/5% D2O	108.6 mM	6.0	1.0 atm	303	Bruker AVANCE III 800
9	3D 1H-13C NOESY aliphatic	500 uM [U-99% 13C; U-99% 15N] VAL88, 7.4 mM potassium phosphate, 1.2 mM sodium phosphate, 100 mM sodium chloride, 95 % H2O, 5 % [U-99% 2H] D2O	95% H2O/5% D2O	108.6 mM	6.0	1.0 atm	303	Bruker AVANCE III 800
10	3D 1H-13C NOESY aromatic	500 uM [U-99% 13C; U-99% 15N] VAL88, 7.4 mM potassium phosphate, 1.2 mM sodium phosphate, 100 mM sodium chloride, 95 % H2O, 5 % [U-99% 2H] D2O	95% H2O/5% D2O	108.6 mM	6.0	1.0 atm	303	Bruker AVANCE III 600
13	3D HCCH-TOCSY aliphatic	500 uM [U-99% 13C; U-99% 15N] VAL88, 7.4 mM potassium phosphate, 1.2 mM sodium phosphate, 100 mM sodium chloride, 95 % H2O, 5 % [U-99% 2H] D2O	95% H2O/5% D2O	108.6 mM	6.0	1.0 atm	303	Bruker AVANCE III 800
11	2D 1H-15N IPAP HSQC	100 uM [U-99% 13C; U-99% 15N] VAL88, 7.4 mM potassium phosphate, 1.2 mM sodium phosphate, 100 mM sodium chloride, 10 mg/mL Pf1 phage, 95 % H2O, 5 % [U-99% 2H] D2O	95% H2O/5% D2O	108.6 mM	6.0	1.0 atm	303	Bruker AVANCE III 950
12	2D 1H-15N IPAP HSQC	100 uM [U-99% 13C; U-99% 15N] VAL88, 7.4 mM potassium phosphate, 1.2 mM sodium phosphate, 100 mM sodium chloride, 10 mg/mL Pf1 phage, 95 % H2O, 5 % [U-99% 2H] D2O	95% H2O/5% D2O	108.6 mM	6.0	1.0 atm	303	Bruker AVANCE III 950

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III	600
2	Bruker	AVANCE III	800
3	Bruker	AVANCE III	950

NMR Refinement
Method	Details	Software
simulated annealing	refinment with RDC values as constrain	CYANA

NMR Ensemble Information
Conformer Selection Criteria	target function
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (target function)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	collection	TopSpin	3.2	Bruker Biospin
2	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
3	chemical shift assignment	NMRView	9.0	Johnson, One Moon Scientific
4	data analysis	MAGRO	2.0.24	Kobayashi, N.
5	chemical shift assignment	CYANA	3.98	Guntert, Mumenthaler and Wuthrich
6	structure calculation	CYANA	3.98	Guntert, Mumenthaler and Wuthrich
7	data analysis	TALOS	TALOS+	Yang, S. and Bax, Ad.
8	refinement	CYANA	3.98	Guntert, Mumenthaler and Wuthrich
9	data analysis	MAGRO	2.01.12	Kobayashi, N. upgraded version of Kujira (Kobayshi, N. et al., 2007)

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.